FI891892A - N-substituerade n-aminopyrroler. - Google Patents

N-substituerade n-aminopyrroler. Download PDF

Info

Publication number
FI891892A
FI891892A FI891892A FI891892A FI891892A FI 891892 A FI891892 A FI 891892A FI 891892 A FI891892 A FI 891892A FI 891892 A FI891892 A FI 891892A FI 891892 A FI891892 A FI 891892A
Authority
FI
Finland
Prior art keywords
aminopyrroler
substituerade
Prior art date
Application number
FI891892A
Other languages
English (en)
Finnish (fi)
Other versions
FI891892A0 (fi
Inventor
Rolf Angerbauer
Walter Huebsch
Peter Fey
Hilmar Bischoff
Dieter Petzinna
Delf Schmidt
Guenter Thomas
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3813776A external-priority patent/DE3813776A1/de
Priority claimed from IT8822264A external-priority patent/IT8822264A0/it
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI891892A0 publication Critical patent/FI891892A0/fi
Publication of FI891892A publication Critical patent/FI891892A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
FI891892A 1988-04-23 1989-04-20 N-substituerade n-aminopyrroler. FI891892A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3813776A DE3813776A1 (de) 1988-04-23 1988-04-23 N-substituierte n-amino-pyrrole
IT8822264A IT8822264A0 (it) 1988-10-11 1988-10-11 N ammino pirroli n sostituiti.

Publications (2)

Publication Number Publication Date
FI891892A0 FI891892A0 (fi) 1989-04-20
FI891892A true FI891892A (fi) 1989-10-24

Family

ID=25867331

Family Applications (1)

Application Number Title Priority Date Filing Date
FI891892A FI891892A (fi) 1988-04-23 1989-04-20 N-substituerade n-aminopyrroler.

Country Status (11)

Country Link
US (1) US4988711A (ko)
EP (1) EP0339342A1 (ko)
JP (1) JPH01313460A (ko)
KR (1) KR900016125A (ko)
CN (1) CN1037145A (ko)
AU (1) AU3312389A (ko)
DK (1) DK196389A (ko)
FI (1) FI891892A (ko)
IL (1) IL90042A0 (ko)
NO (1) NO891480L (ko)
PT (1) PT90342A (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2028538A1 (en) * 1989-10-27 1991-04-28 Hideaki Natsugari 4-substituted isoquinolone derivatives, their production and use
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
AR008789A1 (es) 1996-07-31 2000-02-23 Bayer Corp Piridinas y bifenilos substituidos
WO2001064670A1 (fr) * 2000-02-29 2001-09-07 Mitsubishi Pharma Corporation Nouveaux derives amide cycliques
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
PE20070404A1 (es) * 2005-07-29 2007-05-10 Wyeth Corp Compuestos derivados de cianopirrol-sulfonamida como moduladores del receptor de progesterona

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR900001212B1 (ko) * 1985-10-25 1990-02-28 산도즈 파마슈티칼스 코오포레이숀 메바로노락톤 및 그것의 유도체의 헤테로사이클릭 유사체 및 그것의 생산방법 및 약학적인 그것의 용도

Also Published As

Publication number Publication date
JPH01313460A (ja) 1989-12-18
US4988711A (en) 1991-01-29
NO891480D0 (no) 1989-04-11
FI891892A0 (fi) 1989-04-20
DK196389D0 (da) 1989-04-24
PT90342A (pt) 1989-11-10
KR900016125A (ko) 1990-11-12
AU3312389A (en) 1989-10-26
IL90042A0 (en) 1989-12-15
NO891480L (no) 1989-10-24
DK196389A (da) 1989-10-24
EP0339342A1 (de) 1989-11-02
CN1037145A (zh) 1989-11-15

Similar Documents

Publication Publication Date Title
DE68906637D1 (de) Wafertraeger.
DE58905119D1 (de) Heteroaryloxyessigsaeure-n-isopropylanilide.
FI894834A0 (fi) Piperidinyl-benzimidazoler.
FI895969A0 (fi) Hiss- och transportanordning foer fordon.
DE68921898D1 (de) Ringbinder.
DE58904326D1 (de) Rakelfarbwerk.
DE58904437D1 (de) Rakelfarbwerk.
DE68903708D1 (de) Spielkasten.
DE58902774D1 (de) Pflanztafel.
DE68909215D1 (de) Laseroszillator.
FI890918A (fi) Polypeptider.
DE58902346D1 (de) Traenkeventil.
FI890112A0 (fi) Skumavlaegsningsmedel foer aktivkol innehaollande rengoerningsmedel.
DE58903112D1 (de) Kannenstock.
DE68901775D1 (de) Mammographiegeraet.
FI891892A0 (fi) N-substituerade n-aminopyrroler.
DE58903712D1 (de) Gegenseheinrichtung.
FI83400B (fi) Faestningsklaemma.
DE68905196D1 (de) Faschine.
DE68905146D1 (de) Indanderivate.
DE68904912D1 (de) Ringlaser-kreisel.
DE58908380D1 (de) Benzofuranylbiphenyle.
FI880964A0 (fi) Plastdosa.
FI894040A (fi) Staplingsbar behaollare.
DE68907005D1 (de) Octafluorbiphenyle.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: BAYER AKTIENGESELLSCHAFT